# Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia

> **NCT00683618** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 934 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT00683618
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 934 (ACTUAL)
- **Last updated:** 2012-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00683618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00683618, "Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00683618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*